CareCloud (CCLD) Earnings Date & Reports

Key Takeaways

• CareCloud reported third-quarter 2026 revenue of $33.7 million, up about 9% from $31.1 million a year earlier.
• GAAP (Generally Accepted Accounting Principles) net income reached a record $4.7 million, up 54% year over year, marking the company's 10th straight profitable quarter.
• GAAP earnings per share (EPS) hit a record $0.10, up from $0.04 a year ago, while adjusted EPS of $0.14 topped the $0.12 consensus estimate.
• Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) rose 28% to a record $9.9 million.
• Management reaffirmed full-year 2026 guidance of $128 million to $132 million in revenue and GAAP EPS of $0.20 to $0.23.
• AI-driven claims automation cut manual claim touches by roughly 44% in three months, while the denial rate fell below 4%.
• For more detail on CareCloud's Major News, Today's Price Move, Price Targets, and Forecast, explore our additional pages.
• Discover new trading ideas with our Trending AI Robots.

Earnings Context and Why It Matters

CareCloud's third-quarter report carries outsized weight because it arrives at a pivotal moment in the company's transformation. The healthcare technology and revenue cycle management (RCM) provider has spent recent quarters pivoting toward higher-margin technology, compliance, and artificial intelligence offerings while deliberately stepping back from lower-margin project-based services. After management described the second quarter as a "quarter of building," investors were watching closely to see whether that groundwork would translate into tangible margin expansion. The results also tested the company's newer growth engines, including enterprise AI development and its Empower compliance business, against a top line that has been slowing as acquisition-driven comparisons fade.

Reported Results

CareCloud delivered its most profitable quarter in company history for the three months ended September 30, 2026. Revenue came in at $33.7 million, an increase of roughly 9% from $31.1 million in the prior-year period, modestly ahead of the $33.5 million consensus estimate. GAAP net income climbed 54% year over year to a record $4.7 million, and GAAP EPS reached a record $0.10, up from $0.04 a year earlier. Adjusted EPS of $0.14 beat the $0.12 consensus by about 16.7%. Adjusted EBITDA rose 28% to a record $9.9 million, reflecting a roughly 29% margin.

Gross margin, defined by the company as revenue less direct operating costs, expanded to 50.5% from 47.8% a year ago. Technology-enabled business solutions grew to $24.3 million from $21.6 million. Management reaffirmed full-year 2026 guidance of $128 million to $132 million in revenue, $29 million to $31 million in adjusted EBITDA, and GAAP EPS of $0.20 to $0.23, rather than raising the outlook.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery tool designed to help traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Whether you are tracking earnings movers like CareCloud or searching for emerging setups across the healthcare technology sector, the AI Screener offers a streamlined way to surface actionable ideas.

Market Reaction and Investor Sentiment

Sentiment heading into the report had been cautious, with shares under pressure as revenue growth decelerated from earlier quarters. The record profitability and margin expansion validated the efficiency story management has emphasized, and the company's first quantified AI gains, including a denial rate below 4% versus roughly 8% a year ago and zero-touch claim processing at 84%, gave the operating narrative more substance. Still, the unchanged full-year guidance and the implied modest fourth quarter left some investors unconvinced about near-term top-line momentum. Analysts' most recent rating on the stock is a Hold, with a $2.50 price target.

Forward Outlook and Key Factors to Monitor

Looking ahead, investors will be focused on whether CareCloud can sustain its margin gains while re-accelerating revenue. Management reaffirmed its full-year 2026 outlook, which implies a seasonally softer fourth quarter at or below the third quarter's record profitability. That leaves limited room for upside surprise in the near term.

Several catalysts could shape the next few quarters. The company's enterprise AI platform work with KabaFusion produced its first development revenue in the third quarter, and management plans to report AI revenue separately once it reaches scale. A subscription-based compliance offering built on the Empower acquisition is expected to launch late in the fourth quarter, while AI prior authorization is now live with a pilot client and posting a 91% first-pass approval rate.

On the cost and balance-sheet side, the company continues to pay down the debt tied to its preferred stock redemption, reducing borrowings by roughly $7.4 million in under six months. Investors will be watching whether these efficiency gains continue to flow to common shareholders and whether the shift toward higher-margin technology and compliance offerings can offset the drag from declining project-based professional services revenue.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations